Review



rt-112 bladder pdx model  (Sanofi)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Sanofi rt-112 bladder pdx model
    Rt 112 Bladder Pdx Model, supplied by Sanofi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rt-112+bladder+pdx+model/rt+112+bladder+pdx+model/10__1158_slash_1535___7163__mct___19___0826-238-14-5
    Average 90 stars, based on 1 article reviews
    rt-112 bladder pdx model - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    In Vivo:

    Article Title: An Antibody–Drug Conjugate Targeting MUC1-Associated Carbohydrate CA6 Shows Promising Antitumor Activities
    Article Snippet: The contributions of the following Sanofi employees are greatly appreciated: Yvette Ruffin, pharmacologist for setting-up RT-112 bladder PDX model; Alexandre Rohaut, Ravi Rangara, Isabelle Sanchez, and Marc Malfilatre, pharmacologists who performed in vivo studies; Armelle Gaumet and Françoise Le Gall who performed IHC; Sylvie Guyot and Brigitte Bergaud who performed in vitro and antigen characterization; Patrice Sevestre who performed statistical analysis for epidemiology studies; Patrick Cohen as Project Leader, C ecile Combeau as Global Project Head, SouadNaimi asMolecular Histology Head, Sukhvinder Sidhu as Global Head of Pharmacology, Oncology, and V eronique Blanc for their revision of the manuscript.

    Article Title: An Antibody–Drug Conjugate Targeting MUC1-Associated Carbohydrate CA6 Shows Promising Antitumor Activities
    Article Snippet: 2 Glycosylation is a complex multi-enzyme related process which is frequently deregulated in cancer.. Aberrant glycosylation can lead to the generation of novel tumor surface specific glycotopes that can be targeted by antibodies.. Murine DS6 monoclonal antibody (muDS6) was generated from serous ovary adenocarcinoma immunization.

    Immunohistochemistry:

    Article Title: An Antibody–Drug Conjugate Targeting MUC1-Associated Carbohydrate CA6 Shows Promising Antitumor Activities
    Article Snippet: The contributions of the following Sanofi employees are greatly appreciated: Yvette Ruffin, pharmacologist for setting-up RT-112 bladder PDX model; Alexandre Rohaut, Ravi Rangara, Isabelle Sanchez, and Marc Malfilatre, pharmacologists who performed in vivo studies; Armelle Gaumet and Françoise Le Gall who performed IHC; Sylvie Guyot and Brigitte Bergaud who performed in vitro and antigen characterization; Patrice Sevestre who performed statistical analysis for epidemiology studies; Patrick Cohen as Project Leader, C ecile Combeau as Global Project Head, SouadNaimi asMolecular Histology Head, Sukhvinder Sidhu as Global Head of Pharmacology, Oncology, and V eronique Blanc for their revision of the manuscript.

    Article Title: An Antibody–Drug Conjugate Targeting MUC1-Associated Carbohydrate CA6 Shows Promising Antitumor Activities
    Article Snippet: 2 Glycosylation is a complex multi-enzyme related process which is frequently deregulated in cancer.. Aberrant glycosylation can lead to the generation of novel tumor surface specific glycotopes that can be targeted by antibodies.. Murine DS6 monoclonal antibody (muDS6) was generated from serous ovary adenocarcinoma immunization.

    In Vitro:

    Article Title: An Antibody–Drug Conjugate Targeting MUC1-Associated Carbohydrate CA6 Shows Promising Antitumor Activities
    Article Snippet: The contributions of the following Sanofi employees are greatly appreciated: Yvette Ruffin, pharmacologist for setting-up RT-112 bladder PDX model; Alexandre Rohaut, Ravi Rangara, Isabelle Sanchez, and Marc Malfilatre, pharmacologists who performed in vivo studies; Armelle Gaumet and Françoise Le Gall who performed IHC; Sylvie Guyot and Brigitte Bergaud who performed in vitro and antigen characterization; Patrice Sevestre who performed statistical analysis for epidemiology studies; Patrick Cohen as Project Leader, C ecile Combeau as Global Project Head, SouadNaimi asMolecular Histology Head, Sukhvinder Sidhu as Global Head of Pharmacology, Oncology, and V eronique Blanc for their revision of the manuscript.

    Article Title: An Antibody–Drug Conjugate Targeting MUC1-Associated Carbohydrate CA6 Shows Promising Antitumor Activities
    Article Snippet: 2 Glycosylation is a complex multi-enzyme related process which is frequently deregulated in cancer.. Aberrant glycosylation can lead to the generation of novel tumor surface specific glycotopes that can be targeted by antibodies.. Murine DS6 monoclonal antibody (muDS6) was generated from serous ovary adenocarcinoma immunization.



    Similar Products

    rt-112 bladder pdx model  (Sanofi)
    90
    Sanofi rt-112 bladder pdx model
    Rt 112 Bladder Pdx Model, supplied by Sanofi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rt-112+bladder+pdx+model/rt+112+bladder+pdx+model/10__1158_slash_1535___7163__mct___19___0826-238-14-5
    Average 90 stars, based on 1 article reviews
    rt-112 bladder pdx model - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results